Trials / Completed
CompletedNCT04642001
Association of Two Desensitizing Protocols to Control Dentinal Hypersensitivity in Non-carious Lesions
Association of Two Desensitizing Protocols to Control Dentinal Hypersensitivity in Non-carious Lesions: A Randomized, Double-blind Clinical Trial.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Universidade Federal do Para · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This randomized, double-blind clinical trial evaluated the effect of photobimodulation associated with 8% strontium acetate in the treatment of dentin hypersensitivity in non-carious lesions and analyzed the risk factors with the patient's quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Photon Laser III-DMC (without radiation emission) + My First- Colgate | Positioning of the FBM (Photon Laser III / DMC) without emitting radiation, the equipment's sound was mimicked with the Beep application (Foncannon Inc, Google, © 2018), followed by the use of fluoride-free toothpaste (My First- Colgate) and brushing three times a day. |
| OTHER | Photon Laser III-DMC (without radiation emission) + Sensodyne® Rapid Relief / GSK | Positioning of FBM (Photon Laser III / DMC) without emitting radiation, the equipment's sound was mimicked with the Beep application (Foncannon Inc, Google, © 2018), followed by the application of toothpaste containing strontium acetate (Sensodyne® Rapid Relief / GSK) and brushing three times a day. |
| RADIATION | Photon Laser III-DMC (with irradiation emission) + My First- Colgate | Emission of FBM therapy (Photon Laser III / DMC), followed by the use of fluoride-free toothpaste (My First- Colgate) and brushing three times a day. |
| COMBINATION_PRODUCT | Photon Laser III-DMC (with irradiation emission) +Sensodyne® Rapid Relief / GSK | Emission of FBM therapy (Photon Laser III / DMC), followed by the application of toothpaste containing strontium acetate (Sensodyne® Rapid Relief / GSK) and brushing three times a day. |
Timeline
- Start date
- 2019-08-07
- Primary completion
- 2020-09-15
- Completion
- 2020-11-05
- First posted
- 2020-11-24
- Last updated
- 2020-11-27
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT04642001. Inclusion in this directory is not an endorsement.